Skip to main content

Table 4 The survival data of subgroups according to inflammation response biomarkers

From: An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy

Groups

Cutoff

Patients

3-year OS

5-year OS

P

NLR

   

<0.001

 <3.10

732

76.50%

66.10%

 

 >3.10

220

58.40%

48.80%

 

dNLR

   

<0.001

 <0.499

262

79.50%

62.80%

 

 >0.499

690

65.30%

53.40%

 

PLR

   

<0.001

 <170.58

738

75.00%

63.00%

 

 >170.58

214

65.70%

48.80%

 

LMR

   

<0.001

 <3.53

388

64.60%

77.60%

 

 >3.53

564

54.60%

57.20%

 

SII

   

<0.001

 <781.82

729

75.70%

61.00%

 

 >781.82

233

66.90%

46.70%

 
  1. NLR neutrophil to lymphocyte ratio
  2. dNLR derived neutrophil to lymphocyte ratio
  3. PLR platelet to lymphocyte ratio
  4. LMR lymphocyte to monocyte ratio
  5. SII systematic immune-inflammation index